Gary Brecka Live at the Biohacking 360 Conference 2025 in Romania | TUH #232

Brecka's approach flips the standard hypertension model: rather than assuming the heart is the problem, he investigates homocysteine as a vasomotor irritant. He recounts Dana White's case—after 25 years of brittle hypertension and four medications, a cardiac ablation was scheduled. Brecka's blood test revealed extremely high homocysteine (low 30s mg/dL, goal <9) and multiple methylation gene mutations. Within 21 weeks on TMG, homocysteine dropped, blood pressure normalized, and all medication was ceased. The head of cardiothoracic surgery at Cedars-Sinai, initially hostile, later apologized and now collaborates with Brecka on complex cases. Brecka generalizes this to 85% of hypertension cases he claims are undiagnosed homocysteine/vascular issues.

Brecka critiques the serotonin hypothesis of depression treatment: we say low serotonin causes depression, yet prescribe reuptake inhibitors that never raise serotonin levels. He asks patients on antidepressants for 15-18 years when they expected it to 'kick in'. Instead, he tests for gene mutations and deficiencies, then supplements with the cofactors. He claims that restoring serotonin production via the gut factory resolves depression permanently. He also links postpartum depression to folic acid in prenatal vitamins—women with MTHFR can't convert it, become methylfolate deficient, and symptoms begin during pregnancy, end after stopping the vitamin, leading to false attribution to pregnancy hormones.

Brecka states a maxim: 'The absence of dopamine is the presence of addiction.' He argues that addiction rarely goes away—it shifts from one unhealthy fix to another, sometimes a healthy one, but the root driver remains untreated. He sees children who play video games 12-14 hours a day as future addicts, not because they love gaming but because it normalizes their dopamine levels. In his practice, he first identifies the dopamine deficiency, then provides tyrosine and methylation support. Clinical dependency is easy to break; it's the underlying neurochemical deficit that must be fixed to achieve permanent remission. He contrasts this with pharmaceutical substitutions like Suboxone or Naltrexone, which only replace one exogenous substance with another, not restoring endogenous dopamine.

Brecka argues that the thyroid gets blamed for a crime it didn't commit. In his clinical experience, thousands of patients diagnosed with hypothyroid actually have poor conversion. He checks for gene mutations affecting selenium utilization and often finds them. After supplementing the necessary nutrients, T3 levels normalize and the hypothyroid diagnosis is reversed. He contrasts his approach with the reflexive prescription of Synthroid, Levothyroxine, or Armour thyroid. He also notes that Hashimoto's often involves heavy metals in the thyroid, calling the immune system to attack, further complicating the picture.

Brecka attacks the 1993 USDA mandate for folic acid fortification, calling it a disaster for public mental health. He directly links folic acid to the rise in ADD, ADHD, OCD, bipolar, and postpartum depression. He tells the audience that if an OB/GYN says folic acid prevents neural tube defects, they should clarify that only the converted form does. The recent FDA approval of folinic acid is a major concession to his view. He makes clear that methylfolate is the critical missing piece, and that simply adding more folic acid won't help those with genetic impairments.

Brecka moved from mortality prediction to living with the mission of teaching people to find their missing raw material. His approach is grounded in the mantra: 'We do not pass disease from generation to generation. What we pass from generation to generation is the inability for the body to refine a raw material... This causes a deficiency which leads to that disease. And that deficiency can be fixed.' He does not look at all 20,000+ genes, only about 12 involved in methylation and nutrient conversion. He asserts that if methylation is broken in one cell, it's broken in all 32 trillion, and fixing it globally restores cellular health. He opens the floor at his talks to diagnose any ailment by naming the missing raw material, demonstrating his confidence in this framework.

Brecka uses Dana White's case as the poster child: homocysteine in the low 30s correlated with decades of resistant hypertension. He implies that routine screening of homocysteine is neglected in cardiology despite its strong predictive value. He recommends aiming for a level below 9 µmol/L, which many functional medicine practitioners consider optimal. Lowering homocysteine with TMG and methylated nutrients often normalizes blood pressure, forestalling unnecessary cardiac ablation and lifelong medication. Brecka wants this marker to be as common as cholesterol screening.

This is the overarching protocol Brecka repeats throughout the talk. He emphasizes that he does not possess a 'secret potion' or perform miraculous cures; he simply restores the body's ability to heal itself by putting back the missing raw materials. He likens it to soil testing: if a palm leaf rots, you don't treat the leaf; you test the soil for nitrogen and add it. Human health is analogously a deficiency-state caused by our inability to process nutrients in a synthetic-food environment. His seven-year lifespan extension claim is based on correcting these modifiable risk factors. The approach flips the script from 'what drug treats this condition?' to 'what is missing that caused this condition?'